BioMerieux Other Current Assets 2017-2024 | BMXMF
- BioMerieux other current assets for the quarter ending December 31, 2024 were $0M, a 100% decline year-over-year.
- BioMerieux other current assets for 2024 were $0B, a 0% decline from 2023.
- BioMerieux other current assets for 2023 were $0B, a 0% decline from 2022.
- BioMerieux other current assets for 2022 were $0B, a 100% decline from 2021.
BioMerieux Annual Other Current Assets (Millions of US $) |
|
---|---|
2024 | $0 |
2023 | $0 |
2022 | $0 |
2021 | $9 |
2020 | $0 |
2019 | $0 |
2018 | $0 |
2017 | $2 |
2016 | $0 |
2015 | $0 |
BioMerieux Quarterly Other Current Assets (Millions of US $) |
|
---|---|
2024-12-31 | |
2023-12-31 | |
2023-06-30 | |
2022-12-31 | |
2022-06-30 | $8 |
2021-12-31 | $9 |
2021-06-30 | |
2020-12-31 | |
2019-12-31 | |
2019-06-30 | |
2018-12-31 | $0 |
2018-06-30 | $1 |
2017-12-31 | $2 |
2017-06-30 | |
2016-12-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $16.861B | $4.307B |
bioM?rieux S.A. designs, develops, manufactures and markets systems in the field of vitro diagnostics. The company provides diagnostic solutions which determine the source of disease and contamination. It also offers solutions for managing infectious diseases, cancers and cardiovascular diseases in clinical applications. The company provides solutions for the enumeration of microbial flora, detection of specific pathogenic bacteria, monitoring of air and surface quality and sterility testing for the agri-food, cosmetics and pharmaceutical industries. bioM?rieux S.A. is based in Marcy L Etoile, France. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $141.524B | 26.54 |
CVS Health (CVS) | United States | $81.417B | 10.12 |
Elevance Health (ELV) | United States | $76.834B | 9.91 |
Cencora (COR) | United States | $57.577B | 20.03 |
DiDi Global (DIDIY) | China | $25.180B | 26.75 |
Natera (NTRA) | United States | $21.599B | 0.00 |
Labcorp Holdings (LH) | United States | $20.908B | 16.96 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $13.318B | 0.00 |
CochLear (CHEOY) | Australia | $13.009B | 0.00 |
Solventum (SOLV) | United States | $12.815B | 13.57 |
ICON (ICLR) | Ireland | $12.075B | 11.23 |
Revvity (RVTY) | United States | $11.607B | 19.97 |
Viatris (VTRS) | United States | $10.727B | 3.69 |
Medpace Holdings (MEDP) | United States | $9.208B | 24.45 |
Avantor (AVTR) | United States | $9.009B | 13.09 |
Sonic Healthcare (SKHHY) | Australia | $8.842B | 0.00 |
HealthEquity (HQY) | United States | $8.418B | 36.87 |
Charles River Laboratories (CRL) | United States | $7.762B | 15.21 |
Caris Life Sciences,�Inc (CAI) | United States | $7.052B | 0.00 |
Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
Bausch + Lomb (BLCO) | Canada | $4.840B | 28.50 |
BrightSpring Health Services (BTSG) | United States | $3.571B | 32.76 |
Sotera Health (SHC) | United States | $3.296B | 18.73 |
Surgery Partners (SGRY) | United States | $2.880B | 37.45 |
Alignment Healthcare (ALHC) | United States | $2.651B | 0.00 |
Concentras Parent (CON) | United States | $2.593B | 14.98 |
Organon (OGN) | United States | $2.550B | 2.71 |
GeneDx Holdings (WGS) | United States | $2.351B | 90.54 |
Ardent Health (ARDT) | United States | $2.073B | 8.84 |
Progyny (PGNY) | United States | $2.012B | 44.28 |
PACS (PACS) | United States | $1.966B | 0.00 |
Premier (PINC) | United States | $1.750B | 13.28 |
GoodRx Holdings (GDRX) | United States | $1.725B | 34.50 |
Teladoc Health (TDOC) | United States | $1.451B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.316B | 0.00 | |
Pediatrix Medical (MD) | United States | $1.131B | 8.60 |
CareDx (CDNA) | United States | $1.115B | 17.41 |
Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
Agilon Health (AGL) | United States | $0.931B | 0.00 |
QDM (QDMI) | Hong Kong, SAR China | $0.848B | 291.00 |
AMN Healthcare Services Inc (AMN) | United States | $0.791B | 7.41 |
Nutex Health (NUTX) | United States | $0.645B | 9.76 |
Embecta (EMBC) | United States | $0.606B | 4.08 |
InnovAge Holding (INNV) | United States | $0.582B | 0.00 |
SBC Medicals (SBC) | United States | $0.518B | 0.00 |
LifeMD (LFMD) | United States | $0.514B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.487B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.473B | 10.65 |
Omada Health (OMDA) | $0.452B | 0.00 | |
So-Young (SY) | China | $0.430B | 0.00 |
Enhabit (EHAB) | United States | $0.359B | 29.50 |
COMPASS Pathways (CMPS) | United Kingdom | $0.347B | 0.00 |
Performant Healthcare (PHLT) | United States | $0.331B | 0.00 |
Oncology Institute (TOI) | United States | $0.286B | 0.00 |
Beauty Health (SKIN) | United States | $0.236B | 0.00 |
DocGo (DCGO) | United States | $0.149B | 24.33 |
Pheton Holdings (PTHL) | China | $0.142B | 0.00 |
Sera Prognostics (SERA) | United States | $0.104B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.078B | 0.00 |
KindlyMD (NAKA) | United States | $0.073B | 0.00 |
NeueHealth (NEUE) | United States | $0.061B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.060B | 0.00 |
Basel Medical Group (BMGL) | Singapore | $0.056B | 0.00 |
ModivCare (MODV) | United States | $0.047B | 0.00 |
Biodesix (BDSX) | United States | $0.046B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
OSR Holdings (OSRH) | United States | $0.022B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
SeaStar Medical Holding (ICU) | United States | $0.006B | 0.00 |
XWELL (XWEL) | United States | $0.005B | 0.00 |
Aclarion (ACON) | United States | $0.004B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
INVO Fertility (IVF) | United States | $0.002B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |